Orthofix Medical Inc. Inventory Write-down
Orthofix Medical Inc. (OFIX) reported Inventory Write-down of $400.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2017-02-27
- Orthofix Medical Inc. inventory write-down for the quarter ending 2013-03-31 was $896.00K, a 38.06% increase year-over-year.
- Orthofix Medical Inc. inventory write-down for the quarter ending 2012-12-31 was $8.81M, a 69.25% increase year-over-year.
- Orthofix Medical Inc. inventory write-down for the quarter ending 2012-09-30 was $1.13M, a 16.23% decline year-over-year.
- Orthofix Medical Inc. inventory write-down for the quarter ending 2012-06-30 was $187.00K, a 85.81% decline year-over-year.
- Orthofix Medical Inc. inventory write-down for fiscal 2016 was $400.00K.
- Orthofix Medical Inc. inventory write-down for fiscal 2012 was $10.77M, a 24.27% increase from fiscal 2011.
- Orthofix Medical Inc. inventory write-down for fiscal 2011 was $8.67M, a 17.52% increase from fiscal 2010.
- Orthofix Medical Inc. inventory write-down for fiscal 2010 was $7.38M, a 15.80% decline from fiscal 2009.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month | Inventory Write-down 12 month as first filed |
|---|---|---|---|---|---|
| 2016-12-31 | $400.00K 10-K · filed 2017-02-27 | ||||
| 2013-03-31 | $896.00K 10-Q · filed 2013-05-09 | $9.70M derived: sum of 2 quarters · filed 2014-03-24 | $10.83M derived: sum of 3 quarters · filed 2014-03-24 | $11.02M derived: sum of 4 quarters · filed 2014-03-24 | |
| 2012-12-31 | $8.81M derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-03-24 | $9.94M derived: sum of 2 quarters · filed 2014-03-24 | $10.12M derived: sum of 3 quarters · filed 2014-03-24 | $10.77M 10-K/A · filed 2014-03-24 | $351.00K 10-K · filed 2013-03-01 |
| 2012-09-30 | $1.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $1.32M derived: sum of 2 quarters · filed 2012-11-02 | $1.97M 10-Q · filed 2012-11-02 | $7.17M derived: sum of 4 quarters · filed 2014-03-24 | |
| 2012-06-30 | $187.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-30 | $836.00K 10-Q · filed 2012-07-30 | $6.04M derived: sum of 3 quarters · filed 2014-03-24 | $7.39M derived: sum of 4 quarters · filed 2014-03-24 | |
| 2012-03-31 | $649.00K 10-Q · filed 2013-05-09 | $5.85M derived: sum of 2 quarters · filed 2014-03-24 | $7.20M derived: sum of 3 quarters · filed 2014-03-24 | $8.52M derived: sum of 4 quarters · filed 2014-03-24 | |
| 2011-12-31 | $5.20M derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-03-24 | $6.55M derived: sum of 2 quarters · filed 2014-03-24 | $7.87M derived: sum of 3 quarters · filed 2014-03-24 | $8.67M 10-K/A · filed 2014-03-24 | $5.46M 10-K · filed 2012-02-29 |
| 2011-09-30 | $1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $2.67M derived: sum of 2 quarters · filed 2012-11-02 | $3.46M 10-Q · filed 2012-11-02 | $4.97M derived: sum of 4 quarters · filed 2013-03-01 | |
| 2011-06-30 | $1.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-30 | $2.12M 10-Q · filed 2012-07-30 | $3.62M derived: sum of 3 quarters · filed 2013-03-01 | $5.56M derived: sum of 4 quarters · filed 2013-03-01 | |
| 2011-03-31 | $798.00K 10-Q · filed 2012-05-04 | $2.30M derived: sum of 2 quarters · filed 2013-03-01 | $4.24M derived: sum of 3 quarters · filed 2013-03-01 | ||
| 2010-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $3.44M derived: sum of 2 quarters · filed 2013-03-01 | $7.38M 10-K · filed 2013-03-01 | ||
| 2010-09-30 | $1.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $5.87M 10-Q · filed 2011-10-31 | |||
| 2010-06-30 | $3.93M 10-Q · filed 2011-08-05 | ||||
| 2009-12-31 | $8.76M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |